Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2006 3
2007 2
2008 7
2009 4
2010 4
2011 7
2012 8
2013 5
2014 8
2015 13
2016 17
2017 6
2018 6
2019 16
2020 22
2021 13
2022 14
2023 5
2024 11
2025 16
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Results by year

Filters applied: . Clear all
Page 1
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
Management of patients with hidradenitis suppurativa.
Martorell A, Caballero A, González Lama Y, Jiménez-Gallo D, Lázaro Serrano M, Miranda J, Pascual JC, Salgado-Boquete L, Marín-Jiménez I. Martorell A, et al. Among authors: marin jimenez i. Actas Dermosifiliogr. 2016 Sep;107 Suppl 2:32-42. doi: 10.1016/S0001-7310(17)30007-8. Actas Dermosifiliogr. 2016. PMID: 28081768 Free article. Review. English, Spanish.
Editorial.
Martorell A, Marín-Jiménez I. Martorell A, et al. Among authors: marin jimenez i. Actas Dermosifiliogr. 2016 Sep;107 Suppl 2:1. doi: 10.1016/S0001-7310(17)30001-7. Actas Dermosifiliogr. 2016. PMID: 28081763 Free article. English, Spanish. No abstract available.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
Corrigendum to “Recomendaciones del Grupo Español de Trabajo en enfermedad de Crohn y colitis ulcerosa (GETECCU) sobre la reservoritis en la colitis ulcerosa. Parte 2: Tratamiento” [Gastroenterología y Hepatología 2020;43(10):649-658].
Barreiro-de Acosta M, Marín-Jimenez I, Rodríguez-Lago I, Guarner F, Espín E, Ferrer Bradley I, Gutiérrez A, Beltrán B, Chaparro M, Gisbert JP, Nos P; en representación de GETECCU. Barreiro-de Acosta M, et al. Among authors: marin jimenez i. Gastroenterol Hepatol. 2021 Apr;44(4):320. doi: 10.1016/j.gastrohep.2021.02.001. Epub 2021 Feb 25. Gastroenterol Hepatol. 2021. PMID: 33642094 Free article. English, Spanish. No abstract available.
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU.
Gisbert JP, Donday MG, Riestra S, Lucendo AJ, Benítez JM, Navarro-Llavat M, Barrio J, Morales-Alvarado VJ, Rivero M, Busquets D, Leo Carnerero E, Merino O, Nantes Castillejo Ó, Navarro P, Van Domselaar M, Gutiérrez A, Alonso-Abreu I, Mejuto R, Fernández-Salazar L, Iborra M, Martín-Arranz MD, Pineda JR, Sampedro MJ, Serra Nilsson K, Bouhmidi A, Batista L, Muñoz Villafranca C, Rodríguez-Lago I, Ceballos D, Guerra I, Mañosa M, Marín Jiménez I, Torrella E, Vera Mendoza M, Casanova MJ, de Francisco R, Arias-González L, Marín Pedrosa S, García-Bosch O, García-Alonso FJ, Delgado-Guillena P, García MJ, Torrealba L, Núñez-Ortiz A, Vicuña Arregui M, Bosca-Watts MM, Blázquez I, Acosta D, Garre A, Baldán M, Martínez C, Barreiro-de Acosta M, Domènech E, Esteve M, García-Sánchez V, Nos P, Panés J, Chaparro M; EXIT Study group of GETECCU. Gisbert JP, et al. Among authors: marin jimenez i. Gut. 2025 Feb 6;74(3):387-396. doi: 10.1136/gutjnl-2024-333385. Gut. 2025. PMID: 39794921 Free PMC article. Clinical Trial.
Budesonide for ulcerative colitis.
Marín-Jiménez I, Peña AS. Marín-Jiménez I, et al. Rev Esp Enferm Dig. 2006 May;98(5):362-73. doi: 10.4321/s1130-01082006000500007. Rev Esp Enferm Dig. 2006. PMID: 16944997 Free article. Review. English, Spanish.
Ustekinumab Intravenous Reinduction after Secondary Loss of Response in Patients with Crohn's Disease.
Schreiber S, Lee SD, van der Woude CJ, Marín-Jiménez I, Wolf DC, Schnoy E, Salzberg B, Busse C, Nazar M, Ma T, Borghorst S, Gasink C, Baker T, Godwin B, Adedokun OJ, Feagan BG; POWER Study Group. Schreiber S, et al. Among authors: marin jimenez i. Inflamm Bowel Dis. 2025 Dec 1;31(12):3286-3297. doi: 10.1093/ibd/izaf163. Inflamm Bowel Dis. 2025. PMID: 40971924 Free PMC article. Clinical Trial.
Approach to toxic megacolon.
Gonzáles Lara V, Pérez Calle JL, Marín Jiménez I. Gonzáles Lara V, et al. Among authors: marin jimenez i. Rev Esp Enferm Dig. 2003 Jun;95(6):422-8, 415-21. Rev Esp Enferm Dig. 2003. PMID: 12918536 Review. English, Spanish. No abstract available.
Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA.
Gómez-Labrador C, Ricart E, Iborra M, Iglesias E, Martín-Arranz MD, de Castro L, De Francisco R, García-Alonso FJ, Sanahuja A, Gargallo-Puyuelo CJ, Mesonero F, Casanova MJ, Mañosa M, Rivero M, Calvo M, Sierra-Ausin M, González-Muñoza C, Calvet X, García-López S, Guardiola J, Arias García L, Márquez-Mosquera L, Gutiérrez A, Zabana Y, Navarro-Llavat M, Lorente Poyatos R, Piqueras M, Torrealba L, Bermejo F, Ponferrada-Díaz Á, Pérez-Calle JL, Barreiro-de Acosta M, Tejido C, Cabriada JL, Marín-Jiménez I, Roncero Ó, Ber Y, Fernández-Salazar L, Camps Aler B, Lucendo AJ, Llaó J, Bujanda L, Muñoz Villafranca C, Domènech E, Chaparro M, Gisbert JP. Gómez-Labrador C, et al. Among authors: marin jimenez i. Pharmaceutics. 2024 May 8;16(5):629. doi: 10.3390/pharmaceutics16050629. Pharmaceutics. 2024. PMID: 38794292 Free PMC article.
157 results